Abstract
Less than a quarter of U.S. infants meet the federal recommendation for exclusively breastfeeding to 6 months of age, necessitating access to safe and effective infant formula. The U.S. National Institutes of Health (NIH) and Food and Drug Administration (FDA) held a public Workshop titled “Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework” on September 23rd and September 24th, 2021. Commentary from the NIH and FDA perspectives on the workshop topics is provided in this publication.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call